Cargando…
Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma
BACKGROUND: Gliomas account for more than 60 % of all primary central nervous system neoplasms. Low-grade gliomas display a tendency to progress to more malignant phenotypes and the most frequent and malignant gliomas are glioblastomas (GBM). Another type of glioma, oligodendroglioma originates from...
Autores principales: | Gimenez, Marcela, Marie, Suely Kazue Nagahashi, Oba-Shinjo, Sueli, Uno, Miyuki, Izumi, Clarice, Oliveira, João Bosco, Rosa, Jose Cesar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502388/ https://www.ncbi.nlm.nih.gov/pubmed/26108672 http://dx.doi.org/10.1186/s12885-015-1473-9 |
Ejemplares similares
-
LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation
por: da Silva, Roseli, et al.
Publicado: (2015) -
Correlation of Matrisome-Associatted Gene Expressions with LOX Family Members in Astrocytomas Stratified by IDH Mutation Status
por: Laurentino, Talita de Sousa, et al.
Publicado: (2022) -
Plasmatic membrane toll-like receptor expressions in human astrocytomas
por: Moretti, Isabele Fattori, et al.
Publicado: (2018) -
Metabolism and Brain Cancer
por: Marie, Suely Kazue Nagahashi, et al.
Publicado: (2011) -
Xenograft Transplantation of Human Malignant Astrocytoma Cells Into Immunodeficient Rats: An Experimental Model of Glioblastoma
por: Miura, Flávio Key, et al.
Publicado: (2010)